Elevance Health, Inc. (ELV)

NYSE: ELV · Real-Time Price · USD
330.25
+4.61 (1.42%)
At close: Feb 11, 2026, 4:00 PM EST
330.24
-0.01 (0.00%)
After-hours: Feb 11, 2026, 7:35 PM EST
Market Cap72.89B -23.6%
Revenue (ttm)199.13B +12.6%
Net Income5.66B -5.3%
EPS25.21 -1.8%
Shares Out 220.70M
PE Ratio13.10
Forward PE12.67
Dividend$6.88 (2.08%)
Ex-Dividend DateMar 10, 2026
Volume1,500,468
Open325.00
Previous Close325.64
Day's Range323.30 - 331.31
52-Week Range273.71 - 458.75
Beta0.50
AnalystsBuy
Price Target386.59 (+17.06%)
Earnings DateJan 28, 2026

About ELV

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, a... [Read more]

Sector Healthcare
Founded 1944
Employees 97,100
Stock Exchange NYSE
Ticker Symbol ELV
Full Company Profile

Financial Performance

In 2025, Elevance Health's revenue was $199.13 billion, an increase of 12.62% compared to the previous year's $176.81 billion. Earnings were $5.66 billion, a decrease of -5.32%.

Financial Statements

Analyst Summary

According to 18 analysts, the average rating for ELV stock is "Buy." The 12-month stock price target is $386.59, which is an increase of 17.06% from the latest price.

Price Target
$386.59
(17.06% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Top 15 High-Growth Dividend Stocks For February 2026

My Top 15 dividend growth stocks for February 2026 offer a 1.52% yield, 15.48% five-year dividend growth and are about 27% undervalued.

Other symbols: ACNADPAVGOBMICDWDPZFDS
10 days ago - Seeking Alpha

Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript

Elevance Health, Inc. (ELV) Q4 2025 Earnings Call Transcript

14 days ago - Seeking Alpha

Elevance Health Q4 Earnings Review: No Sign Of An End To The Pain

Elevance Health, Inc. faces persistent margin and volume pressures, with Q4 operating revenue down 55% YoY and weak 2026 guidance. ELV's benefit expense ratio remains elevated at 90%, with medical inf...

14 days ago - Seeking Alpha

US Health Insurer Elevance Health Issues Soft Outlook, Lower Premium Forecast For 2026

Elevance Health Inc. (NYSE: ELV) shares fell after the health insurer reported mixed fourth-quarter 2025 earnings and bleak fiscal 2026 guidance. The stock has recovered most of its loss from the prem...

14 days ago - Benzinga

Elevance Health Stock Dives Again. Why Earnings Are Adding to Medicare Pain.

Elevance Health stock was set to fall for second consecutive day Wednesday.

14 days ago - Barrons

Elevance Health Reports $547 Million Profit Despite Rising Costs

Elevance Health Wednesday reported fourth quarter net income of $547 million as healthcare cost issues continued to drag earnings of the health insurance giant.

14 days ago - Forbes

Elevance forecasts 2026 profit below estimates on elevated medical costs

Elevance Health forecast 2026 profit below Wall Street expectations on Wednesday, as the health insurer expects higher medical costs to persist into the year.

14 days ago - Reuters

Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflect...

14 days ago - Business Wire

U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs

U.S. Managed Care Insurers To Post Lower Q4 2025 Net Income Amid Higher Costs

Other symbols: ALHCCICNCHUMMOHOSCRUNH
15 days ago - Seeking Alpha

Major health insurance stocks sank Tuesday, after Medicare said it was holding payments steady next year

Big health insurers lose nearly $90 billion in market capitalization after Medicare proposed a relatively flat rate increase for next year.

Other symbols: CVSHUMUNH
15 days ago - WSJ

Health Insurer Stocks Flatline on Medicare Rates, UNH Example Trade

Marley Kayden covers the health insurance industry after the Trump administration kept Medicare rates relatively flat, as opposed to the 5%-6% they expected. She also looks at UnitedHealth (UNH), whic...

Other symbols: CVSHUMUNH
15 days ago - Schwab Network

Trump Just Shocked Medicare Stocks — Will Seth Klarman Seize This Moment?

The Medicare Advantage trade just got repriced—by Washington. Donald Trump‘s administration proposed 0.09% rate hike for Medicare Advantage plans in 2027, a fraction of Wall Street's 4%–6% expectation...

Other symbols: CVSHUMUNH
15 days ago - Benzinga

Health insurers tumble after Trump administration proposes keeping Medicare Advantage rates flat next year

Shares of several big-name health care companies plunged after the Trump administration proposed nearly flat rates for Medicare Advantage insurers. In extended trading, Humana, CVS Health and UnitedHe...

Other symbols: CVSHUMUNH
16 days ago - CNBC

Trump Administration proposes keeping steady Medicare rates paid to insurers, WSJ reports

The Trump Administration is proposing to keep Medicare payments to insurers roughly steady next year, the Wall Street Journal reported on Monday, noting the plan includes an average rate increase of j...

Other symbols: CVSHUMUNH
16 days ago - Reuters

Health insurance executives pressed on affordability in Congress

Top executives from five of the nation's largest health insurers began testifying on Thursday to lawmakers in both the U.S. House of Representatives and Senate about the rising costs of Americans' hea...

Other symbols: CICVSUNH
20 days ago - Reuters

Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2025 Results on January 28, 2026

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release fourth quarter and full year 2025 financial results on January 28, 2026, at 6:00 a.m. Eastern Standard Time (“EST”). Management ...

7 weeks ago - Business Wire

Elevance Health Reflects On The Changed Role of Health Plans

INDIANAPOLIS--(BUSINESS WIRE)--As 2025 draws to a close, Elevance Health highlights how today's health plans are evolving to better support their members in a broader range of situations that affect h...

2 months ago - Business Wire

AM Best Takes Various Credit Rating Actions on Elevance Health, Inc. and Most of Its Subsidiaries

OLDWICK, N.J.--(BUSINESS WIRE)-- #insurance--AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of “a+” (Excellent) of t...

2 months ago - Business Wire

Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

INDIANAPOLIS--(BUSINESS WIRE)--The board of directors of Elevance Health (NYSE: ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader...

2 months ago - Business Wire

Anthem Blue Cross and Blue Shield Donates Over $60,000 to Support Holiday Food Distributions Across New York

NEW YORK--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield of New York today announced a donation of more than $60,000 to help fund more than 32 food distribution events in partnership with The Camp...

2 months ago - Business Wire

Impax U.S. Sustainable Economy Fund Q3 2025 Contributors And Detractors

Intel (INTC) rallied strongly in September as the company announced a partnership with Nvidia on integrating Intel's x86 central processing units (CPUs) with Nvidia GPUs in AI server systems. Oracle (...

2 months ago - Seeking Alpha

Elevance Health Expands Virtual Assistant to Help Members Navigate Healthcare with Confidence

INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health announced today that it expanded access of its Virtual Assistant, a digital experience designed to help members easily access information, understand the...

2 months ago - Business Wire

Elevance Health: The Potential Turnaround The Market Isn't Pricing In

Elevance Health is rated a Buy with a $400 price target, reflecting 18% upside and potential market outperformance. ELV trades at a significant discount to peers, with an 11x earnings multiple and str...

2 months ago - Seeking Alpha

Artisan Select Equity Fund Q3 2025 Portfolio Review

Alphabet shares rose 38% during the quarter. This represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Samsung...

Other symbols: ARMKGOOGHSICLRCX
2 months ago - Seeking Alpha

Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached

Health insurance company stocks rose again Wednesday before the Thanksgiving holiday amid hope the Trump administration and Congress can agree on an extension of tax credits for those who buy individu...

Other symbols: OSCR
2 months ago - Forbes